Chemiluminescence detection kit of fumonisin and preparation method thereof
A chemiluminescence detection, fumonisin technology, applied in chemiluminescence/bioluminescence, analysis by chemical reaction of materials, measurement devices, etc., can solve the problems of long detection time, cumbersome time-consuming, low sensitivity, etc. The detection is fast and convenient, the operation is simple and convenient, and the effect of improving the sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Example Embodiment
[0026] Example 1: Construction and preparation of kit 1
[0027] 1. Set up kit 1
[0028] Build a chemiluminescence detection kit for fumonisins, which contains the following components:
[0029] Fumonisin antibody labeled with acridinium ester;
[0030] Fumonisin antigen coupled with carboxyl magnetic beads;
[0031] Chemiluminescence pre-excitation solution A and chemiluminescence excitation solution B;
[0032] Fumonisin series calibrator solutions, the concentrations are: 0 ng / mL, 0.01 ng / mL, 0.1 ng / mL, 1 ng / mL, 10ng / mL, 200 ng / mL;
[0033] The cleaning solution is specifically a Tris-HCl solution with a pH of 7.2 and a concentration of 25 mmol / L, which contains NaCl with a concentration of 0.15 mol / L and 0.05% Tween-20.
[0034] 2. Preparation of magnetic particle suspension coupled with fumonisin antigen
[0035] (1) Take 1 mg of carboxyl magnetic particles in a 0.5 mL centrifuge tube, add 200 μL of 0.1 mol / L MES (pH 5.0) buffer, vortex to mix, place on a magnetic stand
Example Embodiment
[0050] Example 2: Construction and preparation of kit 2
[0051] 1. Construction of Kit 2
[0052] Build a chemiluminescence detection kit for fumonisins, which contains the following components:
[0053] Fumonisin antigen labeled with acridinium ester;
[0054] Carboxylic magnetic beads coupled with fumonisin antibody;
[0055] Chemiluminescence pre-excitation solution A and chemiluminescence excitation solution B;
[0056] Fumonisin series calibrator solutions, the concentrations are: 0 ng / mL, 0.01 ng / mL, 0.1 ng / mL, 1 ng / mL, 10ng / mL, 200 ng / mL;
[0057] The cleaning solution is specifically a Tris-HCl solution with a pH of 7.2 and a concentration of 25 mmol / L, which contains NaCl with a concentration of 0.15 mol / L and 0.05% Tween-20.
[0058] 2. Preparation of magnetic particle suspension conjugated with fumonisin antibody
[0059] (1) Take 1 mg of carboxyl magnetic particles in a 0.5 mL centrifuge tube, add 200 μL of 0.1 mol / L MES (pH 6.0) buffer, vortex to mix, place on a
Example Embodiment
[0074] Example 3: Detection of fumonisins in actual samples
[0075] The operating procedure of the fumonisin quantitative detection kit of the present invention is as follows:
[0076] 1. Sample preparation
[0077] (1) Corn flour sample processing
[0078] Take 1 g of the homogenized sample in a 50 mL centrifuge tube, add 10 mL of 70% methanol-PBS solution, shake vigorously, sonicate for 20 min, let stand for 15 min, centrifuge at 5000 r / min for 8 min, and take 50 μL of the supernatant Put it in a clean glass test tube, add 450μL of pH 8.0 0.1 mol / L phosphate buffer, and mix well to obtain the sample solution to be tested.
[0079] (2) Liquor sample processing
[0080] Take 200 μL of the sample in a centrifuge tube, add 980 μL of pH 8.0 phosphate buffer with a concentration of 0.1 mol / L, and mix well to obtain the sample solution to be tested.
[0081] 2. Testing of the kit
[0082] (1) Add 100 μL of the sample to be tested, 150 μL of the suspension of coupled magnetic particles, and
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap